ꢀ
K. Jakovljevic et al. / C. R. Chimie xxx (xxxx) xxx
11
4.1.2.9. 3,4-Dihydroxy-N-(5-(2-methoxyphenyl)-1,3,4-
thiadiazol-2-yl)benzamide 0.5H2O (3e). Beige powder;
8.2 Hz, AreH); 7.53e7.63 (m, 4H, AreH); 7.87e7.95 (m, 1H,
AreH); 8.02 (d, 1H, J ¼ 1.8 Hz, AreH); 9.42 (s, 1H, OH); 9.95
(s, 1H, OH); 12.88 (s, 1H, NH); 13C NMR (50 MHz, DMSO-d6):
115.26, 116.11, 121.01, 122.22, 125.78, 126.16, 130.24, 131.30,
132.35, 134.08, 145.32, 150.59, 160.08, 160.33, 164.74; IR
(KBr, cmꢁ1): 3421, 3365, 3114, 1659, 1617, 1601, 1518, 1300,
1256, 1115, 753; anal. calcd. for C15H10ClN3O3S (347.78 g/
mol): C, 51.80; H, 2.90; N, 12.08; S, 9.22; found: C, 51.78; H,
2.89; N, 12.09; S, 9.23.
ꢂ
yield: 0.23 g (68%); mp > 250 ꢃC; 1H NMR (200 MHz,
DMSO-d6): 4.03 (s, 3H, OCH3); 6.86 (d, 1H, J ¼ 8.0 Hz,
AreH); 7.13 (t, 1H, J ¼ 8.0 Hz, AreH); 7.27 (d, 1H, J ¼ 8.0 Hz,
AreH); 7.50 (dd, 1H, J ¼ 8.0 and 1.4 Hz, AreH); 7.55 (s, 1H,
AreH); 7.70 (d, 1H, J ¼ 8.0 Hz, AreH); 8.30 (dd, 1H, J ¼ 8.0
and 1.4 Hz, AreH); 10.41 (bs, 2H, OH and 1H, NH); 13C NMR
(50 MHz, DMSO-d6): 54.14, 110.37, 113.16, 113.99, 117.09,
118.85, 19.14, 120.46, 125.32, 129.60, 143.26, 148.41, 153.32,
154.45, 159.27, 162.60; IR (KBr, cmꢁ1): 3398, 3153, 2944,
1681, 1601, 1545, 1526, 1314, 1299, 1260, 1018, 747; anal.
calcd. for C16H13N3O4S ꢂ 0.5H2O (343.36 g/mol): C, 55.97;
H, 3.82; N, 12.24; S, 9.34; found: C, 55.99; H, 3.81; N, 12.26;
S, 9.35.
4.1.2.14. N-(5-(4-Chlorophenyl)-1,3,4-thiadiazol-2-yl)-3,4-
dihydroxybenzamide (3j). White powder; yield: 0.22
g
(64%); mp > 250 ꢃC; 1H NMR (200 MHz, DMSO-d6): 6.86 (d,
1H, J ¼ 8.2 Hz, AreH); 7.55e7.62 (m, 2H, AreH); 7.60 (d, 2H,
JAB ¼ 8.4 Hz, AreH); 7.99 (d, 2H, JBA ¼ 8.4 Hz, AreH); 9.47
(bs, 1H, OH); 9.91 (bs, 1H, OH); 12.84 (bs, 1H, NH); 13C NMR
(50 MHz, DMSO-d6): 115.19, 116.06, 120.96, 122.22, 128.50
(2C), 129.21, 129.35 (2C), 135.04, 145.25, 150.50, 159.80,
160.58, 164.66; IR (KBr, cmꢁ1): 3426, 3182, 1681, 1657, 1614,
1603, 1523, 1455, 1298, 1234, 829; anal. calcd. for
4.1.2.10. 3,4-Dihydroxy-N-(5-(3-methoxyphenyl)-1,3,4-
thiadiazol-2-yl)benzamide ꢂ 0.5H2O (3f). Light brown pow-
der; yield: 0.24 g (70%); mp > 250 ꢃC (Dec.); 1H NMR
(200 MHz, DMSO-d6): 3.85 (s, 3H, OCH3); 6.86 (d, 1H, J ¼
8.0 Hz, AreH); 7.09 (d, 1H, J ¼ 8.0 Hz, AreH); 7.40e7.62 (m,
5H, AreH); 9.68 (bs, 2H, OH); 12.72 (bs, 1H, NH); 13C NMR
(50 MHz, DMSO-d6): 55.49, 111.47, 115.27, 116.12, 116.65,
119.55, 121.00, 122.40, 130.60, 131.69, 145.33, 150.55, 159.78
(2C), 161.62, 164.79; IR (KBr, cmꢁ1): 3386, 3169, 2940, 1676,
1605, 1526, 1457, 1304, 1217, 1217, 1112, 745; anal. calcd. for
C
15H10ClN3O3S (347.78 g/mol): C, 51.80; H, 2.90; N, 12.08; S,
9.22; found: C, 51.84; H, 2.90; N, 12.06; S, 9.19.
4.1.2.15. N-(5-(4-Bromophenyl)-1,3,4-thiadiazol-2-yl)-3,4-
dihydroxybenzamide ꢂ 0.5H2O (3k). Light yellow powder;
yield: 0.21 g (54%); mp > 250 ꢃC; 1H NMR (200 MHz,
DMSO-d6): 6.85 (d, 1H, J ¼ 8.2 Hz, AreH); 7.54e7.61 (m, 2H,
C
16H13N3O4S ꢂ 0.5H2O (343,36 g/mol): C, 55.97; H, 3.82; N,
12.24; S, 9.34; found: C, 55.94; H, 3.83; N, 12.23; S, 9.31.
AreH); 7.73 (d, 2H, JAB ¼ 8.4 Hz, AreH); 7.92 (d, 2H, JBA
¼
8.4 Hz, AreH); 9.48 (bs, 1H, OH); 9.89 (bs, 1H, OH); 12.84
(bs, 1H, NH); 13C NMR (50 MHz, DMSO-d6): 115.26, 116.12,
121.01, 122.29, 123.83, 128.78 (2C), 129.63, 132.34 (2C),
145.32, 150.57, 159.90, 160.72, 164.76; IR (KBr, cmꢁ1): 3391,
3199, 1675, 1605, 1521, 1455, 1299, 1209, 1071, 749; anal.
calcd. for C15H10BrN3O3S ꢂ 0.5H2O (392.23 g/mol): C,
45.93; H, 2.57; N, 10.71; S, 8.18; found: C, 45.92; H, 2.58; N,
10.73; S, 8.19.
4.1.2.11. 3,4-Dihydroxy-N-(5-(4-methoxyphenyl)-1,3,4-
thiadiazol-2-yl)benzamide ꢂ H2O (3g). Beige powder; yield:
0.18 g (51%); mp > 250 ꢃC; 1H NMR (200 MHz, DMSO-d6):
3.83 (s, 3H, OCH3); 6.85 (d, 1H, J ¼ 8.4 Hz, AreH); 7.08 (d,
2H, JAB ¼ 8.8 Hz, AreH); 7.54 (s, 1H, AreH); 7.59 (d, 1H, J ¼
8.2 Hz, AreH); 7.90 (d, 2H, JBA ¼ 8.8 Hz, AreH); 9.66 (bs, 2H,
OH); 12.65 (bs, 1H, NH); 13C NMR (50 MHz, DMSO-d6):
55.56, 114.84 (2C), 115.27, 116.11, 120.96, 122.49, 123.00,
128.51 (2C), 145.33, 150.51, 159.04, 161.06, 161.61, 164.72; IR
(KBr, cmꢁ1): 3397, 3181, 2937, 1663, 1607, 1521, 1462, 1305,
1258, 1178, 829; anal. calcd. for C16H13N3O4S ꢂ H2O
(343.36 g/mol): C, 55.97; H, 3.82; N, 12.24; S, 9.34; found: C,
55.98; H, 3.80; N, 12.27; S, 9.36.
4.1.2.16. N-(5-Benzyl-1,3,4-thiadiazol-2-yl)-3,4-
dihydroxybenzamide (3l). Gray powder; yield: 0.19
g
(57%); mp > 250 ꢃC (Dec.); 1H NMR (200 MHz, DMSO-d6):
4.36 (s, 2H, CH2); 6.82 (d, 1H, J ¼ 8.2 Hz, AreH); 7.24e7.37
(m, 5H, AreH); 7.48 (s, 1H, AreH); 7.52 (d, 1H, J ¼ 8.2 Hz,
AreH); 9.38 (s, 1H, OH); 9.88 (s, 1H, OH); 12.57 (s, 1H,
NH); 13C NMR (50 MHz, DMSO-d6): 35.20, 115.23, 116.04,
120.85, 122.48, 127.06, 128.84 (2C), 128.91 (2C), 137.92,
145.27, 150.40, 159.90, 163.53, 164.67; IR (KBr, cmꢁ1):
3433, 3347, 3063, 1673, 1612, 1527, 1454, 1304, 1218, 750;
anal. calcd. for C16H13N3O3S (327.36 g/mol): C, 58.70; H,
4.00; N, 12.84; S, 9.80; found: C, 58.65; H, 3.98; N, 12.80;
S, 9.83.
4.1.2.12. N-(5-(2-Chlorophenyl)-1,3,4-thiadiazol-2-yl)-3,4-
dihydroxybenzamide ꢂ H2O (3h). Beige powder; yield: 0.21 g
(61%); mp > 250 ꢃC; 1H NMR (200 MHz, DMSO-d6): 6.86 (d,
1H, J ¼ 8.2 Hz, AreH); 7.49e7.62 (m, 4H, AreH); 7.65e7.72
(m, 1H, AreH); 8.12e8.17 (m, 1H, AreH); 9.59 (bs, 1H, OH);
9.80 (bs, 1H, OH); 12.85 (bs, 1H, NH); 13C NMR (50 MHz,
DMSO-d6): 115.28, 116.14, 121.05, 122.27, 127.90, 129.25,
130.64, 130.93, 131.16, 131.75, 145.34, 150.60, 157.86, 161.25,
164.84; IR (KBr, cmꢁ1): 3420, 3160, 2969, 1684, 1606, 1527,
1451, 1300, 1203, 753; anal. calcd. for C15H10ClN3O3S ꢂ H2O
(347.78 g/mol): C, 51.80; H, 2.90; N, 12.08; S, 9.22; found: C,
51.82; H, 2.91; N, 12.10; S, 9.20.
4.1.2.17. 3,4-Dihydroxy-N-(5-(phenoxymethyl)-1,3,4-
thiadiazol-2-yl)benzamide (3m). Beige powder; yield: 0.26 g
(75%); mp > 250 ꢃC; 1H NMR (200 MHz, DMSO-d6): 5.51 (s,
2H, CH2); 6.84 (d, 1H, J ¼ 8.2 Hz, AreH); 7.00 (t, 1H, J ¼
7.4 Hz, AreH); 7.08 (d, 2H, J ¼ 8.2 Hz, AreH); 7.33 (t, 2H, J ¼
8.2 Hz, AreH); 7.51 (s, 1H, AreH); 7.56 (d, 1H, J ¼ 8.2 Hz,
AreH); 9.43 (bs, 1H, OH); 9.89 (s, 1H, OH); 12.73 (s, 1H, NH);
13C NMR (50 MHz, DMSO-d6): 64.22, 115.08 (2C), 115.26,
4.1.2.13. N-(5-(3-Chlorophenyl)-1,3,4-thiadiazol-2-yl)-3,4-
dihydroxybenzamide (3i). White powder; yield: 0.19 g (54%);
mp > 250 ꢃC; 1H NMR (200 MHz, DMSO-d6): 6.86 (d, 1H, J ¼
ꢀ
Please cite this article as: K. Jakovljevic et al., Novel 1,3,4-thiadiazole conjugates derived from protocatechuic acid: Synthesis,
j.crci.2019.06.001